Carr B R, Rainey W E, Mason J I
Endocrinology. 1987 Mar;120(3):995-9. doi: 10.1210/endo-120-3-995.
The adrenal gland of the human fetus (HFA) is relatively large compared to that of the adult and exhibits an extremely high rate of steroidogenesis both in vivo and in vitro. The fetal zone cells make up 80-85% of the volume of the HFA and are the major site of steroid production during fetal development. We have recently demonstrated that calcium is involved in the regulation of steroidogenesis in fetal zone cells of the HFA. There is considerable evidence that many actions of calcium within cells are mediated by the calcium-binding protein calmodulin. The purpose of the present investigation was to determine if calmodulin also plays a role in HFA steroidogenesis. To investigate this possibility, the fetal zone was dissected from fetal adrenals of first and second trimester human abortuses. After collagenase digestion of the tissue, dispersed fetal zone cells were maintained in a Krebs-Ringers medium at 37 C for a 3-h incubation. Cells were incubated with and without ACTH (10(-8) M) in the presence of the calmodulin inhibitors trifluoperazine (TFP), chlorpromazine (CPZ), and calmidazolium (CAL) at concentrations of 5-100 microM. The media were assayed for contents of dehydroepiandrosterone sulfate (DS), cortisol (F), pregnenolone, and cAMP by RIA. The addition of ACTH stimulated F secretion 5- to 10-fold compared to that in control fetal zone cells. DS secretion increased up to 5-fold and pregnenolone about 2-fold in the presence of ACTH compared to values in control cells. ACTH also stimulated cAMP secretion by 10-fold compared to that in control cells. The addition of TFP, CPZ, and CAL significantly inhibited ACTH-stimulated DS, F, and pregnenolone secretion in a dose-related fashion to near-control levels. We observed that TFP, CPZ, and CAL inhibited cAMP accumulation as well as Bu2cAMP-stimulated steroid secretion. The metabolism of 22R-hydroxycholesterol to pregnenolone was inhibited by TFP and CPZ, but not by CAL. These studies suggest that calmodulin plays a role in regulating steroidogenesis in fetal zone cells of the HFA.
与成人相比,人类胎儿肾上腺(HFA)相对较大,且在体内和体外均表现出极高的类固醇生成率。胎儿带细胞占HFA体积的80 - 85%,是胎儿发育过程中类固醇产生的主要部位。我们最近证明,钙参与了HFA胎儿带细胞中类固醇生成的调节。有大量证据表明,细胞内钙的许多作用是由钙结合蛋白钙调蛋白介导的。本研究的目的是确定钙调蛋白是否也在HFA类固醇生成中发挥作用。为了研究这种可能性,从孕早期和孕中期人工流产胎儿的肾上腺中分离出胎儿带。组织经胶原酶消化后,将分散的胎儿带细胞在37℃的Krebs - Ringers培养基中孵育3小时。在存在浓度为5 - 100μM的钙调蛋白抑制剂三氟拉嗪(TFP)、氯丙嗪(CPZ)和平痛新(CAL)的情况下,将细胞分别在有和无促肾上腺皮质激素(ACTH,10(-8) M)的条件下孵育。通过放射免疫分析法测定培养基中硫酸脱氢表雄酮(DS)、皮质醇(F)、孕烯醇酮和环磷酸腺苷(cAMP)的含量。与对照胎儿带细胞相比,添加ACTH可使F分泌增加5至10倍。与对照细胞相比,在ACTH存在下,DS分泌增加高达5倍,孕烯醇酮增加约2倍。与对照细胞相比,ACTH还可使cAMP分泌增加10倍。添加TFP、CPZ和CAL以剂量相关的方式显著抑制ACTH刺激的DS、F和孕烯醇酮分泌,使其接近对照水平。我们观察到TFP、CPZ和CAL抑制cAMP积累以及双丁酰环磷腺苷(Bu2cAMP)刺激的类固醇分泌。TFP和CPZ抑制22R - 羟基胆固醇向孕烯醇酮的代谢,但CAL无此作用。这些研究表明,钙调蛋白在调节HFA胎儿带细胞的类固醇生成中发挥作用。